๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Ida-FLAG plus imatinib mesylate-induced molecular remission in a patient with chemoresistant Ph1(+) acute myeloid leukemia

โœ Scribed by Nora-Athina Viniou; Theodoros P. Vassilakopoulos; Xanthi Giakoumi; Marina Mantzouranis; Gerassimos A. Pangalis


Book ID
114424465
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
80 KB
Volume
72
Category
Article
ISSN
0902-4441

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Secondary myelodysplastic syndrome in a
โœ Arturo Vega-Ruiz; Susan Oโ€™Brien; Jorge Cortes; Partow Kebriaei; Deborah Thomas; ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 90 KB

The addition of imatinib to high-intensity chemotherapy has improved the outcome of patients with Philadelphia chromosome (Ph)-positive acute lymphoblastic leukemia (ALL). However, the possible long-term side effects of this combination are not yet known. Development of new clonal abnormalities in c